Background： Recent studies have indicated that an imbalance of gut microbiota is associated with the development of type 1 diabetes mellitus （TI DM） and there is no literature regarding it in Chinese children yet. ...Background： Recent studies have indicated that an imbalance of gut microbiota is associated with the development of type 1 diabetes mellitus （TI DM） and there is no literature regarding it in Chinese children yet. The aim of this study was to evaluate the alteration of gut microbiota between children with newly diagnosed T 1DM and healthy controls and to determine if gut microbiota could partly explain the etiology of this disease. Methods： A case-control study was carried out with 15 children with T 1 DM and 15 healthy children. The fecal bacteria composition was investigated by high-throughput sequencing of the V3-V4 region of the 16S rDNA gene and analyzed by the estimators of community richness （Chao） indexes. Results： There was a notable lower richness of fecal bacteria in T1DM group than controls （156.53 ± 36.96 vs. 130.0 ± 32.85, P - 0.047）. At the genus level, the composition of Blautia was increased in T 1 DM group than control group whereas the composition of Haemophilus, Lachnospira, Dialister, and Acidaminococcus was decreased. In addition, we found that the percentage of Blautia was correlated positively with HbA 1 c （p = 0.40, P - 0.031）, the numbers of T1DM autoantibodies （p = 0.42, P = 0.023）, and the titers of tyrosine phosphatase autoantibodies （IA-2） （p= 0.82, P = 0.000） in the study. Conclusions： This study showed that gut microbiota was associated with the development of T 1DM by affecting the autoimmunity, and the results suggested a potential therapy for T1DM via modulating the gut microbiota.展开更多
文摘Background： Recent studies have indicated that an imbalance of gut microbiota is associated with the development of type 1 diabetes mellitus （TI DM） and there is no literature regarding it in Chinese children yet. The aim of this study was to evaluate the alteration of gut microbiota between children with newly diagnosed T 1DM and healthy controls and to determine if gut microbiota could partly explain the etiology of this disease. Methods： A case-control study was carried out with 15 children with T 1 DM and 15 healthy children. The fecal bacteria composition was investigated by high-throughput sequencing of the V3-V4 region of the 16S rDNA gene and analyzed by the estimators of community richness （Chao） indexes. Results： There was a notable lower richness of fecal bacteria in T1DM group than controls （156.53 ± 36.96 vs. 130.0 ± 32.85, P - 0.047）. At the genus level, the composition of Blautia was increased in T 1 DM group than control group whereas the composition of Haemophilus, Lachnospira, Dialister, and Acidaminococcus was decreased. In addition, we found that the percentage of Blautia was correlated positively with HbA 1 c （p = 0.40, P - 0.031）, the numbers of T1DM autoantibodies （p = 0.42, P = 0.023）, and the titers of tyrosine phosphatase autoantibodies （IA-2） （p= 0.82, P = 0.000） in the study. Conclusions： This study showed that gut microbiota was associated with the development of T 1DM by affecting the autoimmunity, and the results suggested a potential therapy for T1DM via modulating the gut microbiota.
